SCHEMBL3046876

SCHEMBL3046876

Cc1c(-c2ccc(OCCNCC3CCCCC3)cc2)ccc2[nH]cnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 7/20 0.43
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4E B2RXH2 2/20 0.35
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
PRKCQ Q04759 1/20 0.34
PRKCD Q05655 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HRH3 Q9Y5N1 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3039718 0.90 HRH4 (0.39) HRH4MEN1KMT2AKDM4ECCNB2
Trifluoroacetic Acid SCHEMBL3046355 0.78 HDAC6 (0.40) DRD2DRD4DRD3
SCHEMBL13136892 0.77 PIK3CA (0.44) GSK3AALDH1A1ADRB1ADRB3
SCHEMBL13136904 0.77 MEN1 (0.37) HRH4MEN1KMT2AKDM4ECYP1A2
Hydrochloric Acid SCHEMBL3051485 0.77 DRD2 (0.40) HRH4PRKCQPRKCDDRD2DRD4
Hydrochloric Acid SCHEMBL3050415 0.76 HDAC3 (0.41) HRH4CD274
Hydrochloric Acid SCHEMBL3046520 0.75 SIGMAR1 (0.43) DRD2DRD4DRD3CD274
Hydrochloric Acid SCHEMBL3047168 0.75 PRMT5 (0.39) KMT2AKDM4ECYP1A2CYP2D6CYP2C19
Trifluoroacetic Acid SCHEMBL3054801 0.75 VSIR (0.42) DRD2DRD4DRD3
Trifluoroacetic Acid SCHEMBL3047291 0.73 HTR5A (0.41) HRH4MEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS OPRL1, OPRM1, OPRK1 HRH4 308/4885MEN1 4829/4885KMT2A 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.